Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
The Yale Journal of Biology and Medicine
|
November 26, 2015
Crowdfunding for Personalized Medicine Research
Danielle C Fumagalli, Arvin M Gouw
Advances in Experimental Medicine and Biology
|
May 20, 2021
Cancer Stem Cell Metabolism
Fidelia B Alvina, Arvin M Gouw, Anne Le
Oncotarget
|
February 11, 2016
Metabolic vulnerabilities of MYC-induced cancer
Arvin M Gouw, Georgia G Toal, Dean W Felsher
Learning & Memory (Cold Spring Harbor, N.Y.)
|
July 12, 2007
Age-related decline of sleep-dependent consolidation
Rebecca M C Spencer, Arvin M Gouw, Richard B Ivry
Nature Communications
|
March 24, 2017
Correspondence: Oncogenic MYC persistently upregulates the molecular clock component REV-ERBα
Brian J Altman, Annie L Hsieh, Arvin M Gouw, et al.
Physiological Genomics
|
December 25, 2016
Roles of estrogen receptor-alpha in mediating life span: the hypothalamic deregulation hypothesis
Arvin M Gouw, Gizem Efe, Rita Barakat, et al.
Nature Reviews. Clinical Oncology
|
September 11, 2021
The MYC oncogene - the grand orchestrator of cancer growth and immune evasion
Renumathy Dhanasekaran, Anja Deutzmann, Wadie D Mahauad-Fernandez, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 5, 2014
Alteration of the lipid profile in lymphomas induced by MYC overexpression
Livia S Eberlin, Meital Gabay, Alice C Fan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 13, 2017
Oncogene KRAS activates fatty acid synthase, resulting in specific ERK and lipid signatures associated with lung adenocarcinoma
Arvin M Gouw, Livia S Eberlin, Katherine Margulis, et al.
Oncotarget
|
March 19, 2015
p19ARF is a critical mediator of both cellular senescence and an innate immune response associated with MYC inactivation in mouse model of acute leukemia
Alper Yetil, Benedict Anchang, Arvin M Gouw, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
The Yale Journal of Biology and Medicine
|
November 26, 2015
Crowdfunding for Personalized Medicine Research
Danielle C Fumagalli, Arvin M Gouw
Advances in Experimental Medicine and Biology
|
May 20, 2021
Cancer Stem Cell Metabolism
Fidelia B Alvina, Arvin M Gouw, Anne Le
Oncotarget
|
February 11, 2016
Metabolic vulnerabilities of MYC-induced cancer
Arvin M Gouw, Georgia G Toal, Dean W Felsher
Learning & Memory (Cold Spring Harbor, N.Y.)
|
July 12, 2007
Age-related decline of sleep-dependent consolidation
Rebecca M C Spencer, Arvin M Gouw, Richard B Ivry
Nature Communications
|
March 24, 2017
Correspondence: Oncogenic MYC persistently upregulates the molecular clock component REV-ERBα
Brian J Altman, Annie L Hsieh, Arvin M Gouw, et al.
Physiological Genomics
|
December 25, 2016
Roles of estrogen receptor-alpha in mediating life span: the hypothalamic deregulation hypothesis
Arvin M Gouw, Gizem Efe, Rita Barakat, et al.
Nature Reviews. Clinical Oncology
|
September 11, 2021
The MYC oncogene - the grand orchestrator of cancer growth and immune evasion
Renumathy Dhanasekaran, Anja Deutzmann, Wadie D Mahauad-Fernandez, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 5, 2014
Alteration of the lipid profile in lymphomas induced by MYC overexpression
Livia S Eberlin, Meital Gabay, Alice C Fan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 13, 2017
Oncogene KRAS activates fatty acid synthase, resulting in specific ERK and lipid signatures associated with lung adenocarcinoma
Arvin M Gouw, Livia S Eberlin, Katherine Margulis, et al.
Oncotarget
|
March 19, 2015
p19ARF is a critical mediator of both cellular senescence and an innate immune response associated with MYC inactivation in mouse model of acute leukemia
Alper Yetil, Benedict Anchang, Arvin M Gouw, et al.
Page
of 3